
Skye Bioscience, Inc.
SKYEHealthcare|Biotechnology|US
$0.99
-0.05 (-4.78%)
DCF Value
$0.79
Cash / Share
$2.03
Next Earnings Report
Mar 25, 2027
EPS est. -$1.06
Financing Filings (last 12 months)
0
No shelf registrations or offering prospectuses filed.
Upcoming Data Readouts (1)
Nov 2026
Est. completion
P2Obesity
Study to Evaluate the Effect on Obesity of QW Nimacimab and QW Nimacimab Co-administered With Semaglutide vs Placebo
NCT06577090n=136
Recent Press Releases
Skye Bioscience and Redx Pharma Announce Transaction Agreement and $125 Million in Financings
Aug 14, 2026 · GlobeNewsWire
SEC Filings (56)
Last two years from EDGAR. Insider Form 4s are on the Ownership tab.
| Filed | Form | What it is | Links |
|---|---|---|---|
| Oct 28, 2026 | PRER14A | DocumentIndex | |
| Oct 26, 2026 | PREM14A | DocumentIndex | |
| Oct 14, 2026 | SC 13G | Passive 5%+ stake | DocumentIndex |
| Sep 24, 2026 | SC 13D/A | Activist / 5%+ stake | DocumentIndex |
| Sep 11, 2026 | DEFA14A | Proxy / shareholder vote | DocumentIndex |
| Sep 11, 2026 | 8-K | Material event | DocumentIndex |
| Aug 24, 2026 | DEFA14A | Proxy / shareholder vote | DocumentIndex |
| Aug 24, 2026 | 8-K | Material event | DocumentIndex |
| Aug 20, 2026 | DEFA14A | Proxy / shareholder vote | DocumentIndex |
| Aug 20, 2026 | 8-K/A | Material event | DocumentIndex |
| Aug 19, 2026 | DEFA14A | Proxy / shareholder vote | DocumentIndex |
| Aug 19, 2026 | 8-K | Material event | DocumentIndex |
| Aug 18, 2026 | SC 13D/A | Activist / 5%+ stake | DocumentIndex |
| Aug 14, 2026 | DEFA14A | Proxy / shareholder vote | DocumentIndex |
| Aug 14, 2026 | 10-Q | Quarterly report | DocumentIndex |
| Aug 14, 2026 | 8-K | Material event | DocumentIndex |
| Jun 23, 2026 | 8-K | Material event | DocumentIndex |
| May 29, 2026 | 8-K | Material event | DocumentIndex |
| May 15, 2026 | 8-K | Material event | DocumentIndex |
| May 11, 2026 | 10-Q | Quarterly report | DocumentIndex |
| Apr 16, 2026 | ARS | Annual report to holders | DocumentIndex |
| Apr 16, 2026 | DEFA14A | Proxy / shareholder vote | DocumentIndex |
| Apr 16, 2026 | DEF 14A | Proxy / shareholder vote | DocumentIndex |
| Apr 6, 2026 | PRE 14A | Proxy / shareholder vote | DocumentIndex |
| Apr 6, 2026 | PREM14A | DocumentIndex | |
| Apr 6, 2026 | 8-K/A | Material event | DocumentIndex |
| Apr 3, 2026 | 8-K | Material event | DocumentIndex |
| Mar 19, 2026 | 8-K | Material event | DocumentIndex |
| Mar 11, 2026 | S-8 | Employee stock plan | DocumentIndex |
| Mar 10, 2026 | 8-K | Material event | DocumentIndex |
| Mar 10, 2026 | 10-K | Annual report | DocumentIndex |
| Feb 20, 2026 | 8-K | Material event | DocumentIndex |
| Feb 2, 2026 | 8-K | Material event | DocumentIndex |
| Dec 23, 2025 | 8-K | Material event | DocumentIndex |
| Dec 16, 2025 | SC 13D/A | Activist / 5%+ stake | DocumentIndex |
| Nov 10, 2025 | 8-K | Material event | DocumentIndex |
| Nov 10, 2025 | 10-Q | Quarterly report | DocumentIndex |
| Oct 6, 2025 | 8-K | Material event | DocumentIndex |
| Aug 14, 2025 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| Aug 7, 2025 | 8-K | Material event | DocumentIndex |